Related Experiment Video
Updated: Apr 28, 2026

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Aluminum transfer during dialysis: a systematic review
Joëlle Mardini1, Valery Lavergne, Marc Ghannoum
1Nephrology Department, Verdun Hospital, University of Montreal, 4000 Lasalle Blvd, Montreal, QC, Canada.
Aluminum transfer during dialysis is predictable by comparing plasma and dialysate concentrations. Maintaining dialysate aluminum below 4 μg/L is crucial to prevent toxicity in dialysis-dependent patients.
Area of Science:
- Nephrology
- Toxicology
- Biochemistry
Background:
- Dialysis-dependent patients are vulnerable to aluminum toxicity due to impaired excretion.
- Aluminum contamination in dialysis fluid poses a significant risk.
- The mechanism of aluminum diffusion across dialysis membranes requires clarification.
Purpose of the Study:
- To test the hypothesis that aluminum transfer direction is determined by the concentration gradient between plasma and dialysate.
- To establish a predictive model for aluminum movement across dialysis membranes.
Main Methods:
- Systematic literature review of studies reporting plasma and dialysate aluminum concentrations and transfer direction.
- Inclusion of data from four patients from the authors' cohort.
- Analysis based on the ultrafiltrable fraction of plasma aluminum (17-23%) to define transfer scenarios.
Main Results:
- Out of 115 analyzed patients, 94% (108 patients) demonstrated aluminum transfer consistent with the hypothesis.
- Only three out of 111 patients showed results contrary to the predicted direction of aluminum transfer.
- The concentration gradient effectively predicts aluminum transfer direction in most cases.
Conclusions:
- Comparing ultrafiltrable plasma aluminum to dialysate aluminum accurately predicts transfer direction.
- Optimal dialysate aluminum concentration should be less than 20% of the maximum acceptable plasma level.
- To adhere to K/DOQI guidelines (plasma Al < 20 μg/L), dialysate Al should not exceed 4 μg/L; current K/DOQI recommendations (dialysate Al < 10 μg/L) may permit toxic plasma levels.
More Related Videos
Related Concept Videos
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Hemodialysis I: Introduction
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Acute Kidney Injury V: Interprofessional Care
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

